
Telehealth gaps allow anorexia patients to easily access dangerous weight-loss drugs
A Yale study found that 92% of telehealth sites prescribed GLP-1 weight-loss drugs to fake profiles, often without asking about eating disorders. Clinicians report rising cases of anorexia patients using these drugs to suppress hunger cues, leading to severe malnutrition. Telehealth companies claim they screen for disordered eating, but critics argue lax regulations and rapid prescribing processes prioritize speed over safety. Regulators are beginning to address compounding and advertising issues, but enforcement remains inconsistent across states.









